Leena H. Saeed1*, Nahed Y Lubbad2**, Esraa A Mahmoud 3, Bennette M Alejandro4
1*Principle Investigator: Clinical pharmacist, Neurology, King Fahad Medical city, Riyadh, KSA
2**Co-Investigator: Clinical pharmacist, Neurology, King Fahad Medical City, Riyadh, KSA
3MD, Alfaisal University, Riyadh, KSA
4Pharmacist assistant, King Fahad Medical City, Riyadh, KSA
*Corresponding Author: Leena H Saeed, Clinical pharmacist, Neurology, King Fahad Medical city, Riyadh, KSA.
Received: September 14, 2020; Published: October 12, 2020
Most of the hospital admitted patients with severe diseases are usually started on intravenous (IV) medications, in particular, those who are released from operation room to intensive care units. Although IV to oral therapy conversion is not suitable for critical patients or those who are unable to absorb orally, there is still a good number of patients in each hospital, who are candidates for the switchover from IV to oral therapy.
Keywords: IV to Oral, Pharamcoeconomic, Switch, Hospitalized
Citation: Leena H Saeed., et al. “Early Switch from Intravenous to Oral Therapy in Hospitalized Patients in Neuroscience Center at KFMC: A Cost-minimization Approach". Acta Scientific Medical Sciences 4.11 (2020): 21-26.
Copyright: © 2020 Leena H Saeed et al This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.